Human medicines European public assessment report (EPAR): Yuviwel, Navepegritide, Status: OpinionHuman medicines European public assessment report (EPAR): Kizfizo, temozolomide, Status: OpinionHuman medicines European public assessment report (EPAR): Foundayo, Orforglipron, Status: OpinionHuman medicines European public assessment report (EPAR): Neuzafy, filgrastim, Status: OpinionHuman medicines European public assessment report (EPAR): Fovlussea, ranibizumab, Ophthalmologicals, Status: Opinion